Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 16 Dec 2022 07:00 CET |
AELIS FARMA | Aelis Farma Announces the Recruitment of the First Patient for the Phase 1/2 Clinical Trial of Its Drug Candidate AEF0217 for the Treatment of Cognitive Disorders in Down Syndrome | 20103010 Biotechnology | Other subject |
| 16 Dec 2022 07:00 CET |
AELIS FARMA | Aelis Farma annonce le recrutement du premier patient de l’étude clinique de phase 1/2 avec son candidat-médicament AEF0217 pour le traitement des troubles cognitifs de la trisomie 21 | 20103010 Biotechnology | Other subject |